Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of Oral Hymecromone to Treat Adolescents and Adults With Primary Sclerosing Cholangitis(HAAPS Study).

NCT05295680 is registered in ClinicalTrials.gov with Aparna Goel as lead sponsor.

NCT NCT05295680
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05295680 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of Oral Hymecromone to Treat Adolescents and Adults With Primary Sclerosing Cholangitis(HAAPS Study).
Lead sponsor
Aparna Goel
Phase
Phase 2
Overall status
Recruiting
Start date
May 10, 2023
Completion date
December 31, 2027
Enrollment
24 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

primary sclerosing cholangitis